PMC8191501_01
Clinical imaging. For clinical case 1, the CT scan shows a progressive size reduction of primary tumor localized in the left superior lobe (B, C) in comparison with baseline (A). For clinical case 2, the CT scan (E) shows dimensional increase of primary tumor localized in the right superior lobe in comparison with baseline (D). This increase could be explained as a pseudo-progression because of the reduction of the same lesion in the subsequent CT scan (F). For clinical case 3, the CT scan (H, I) shows a size reduction of primary tumor localized in the left superior lobe in comparison with baseline (G); in H, the signs of a partial cavitation (arrow) for necrosis can also be observed. (J) The graph shows the changes in the sum of the diameters of target lesions at T0, T1 and T2. The classification of response according to the RECIST criteria is associated with each time point. mm, millimeters; PD, progressive disease; SD, stable disease; PR, partial response.
fimmu-12-672219-g001.jpg
PMC8191501_03_fimmu-12-672219-g001.jpg
f1
At the subsequent evaluation two months later (T2), the CT scan still showed stable disease according with RECIST criteria ( Figures 1G-I ,  J ).
PMC8191501_02
Clinical imaging. For clinical case 1, the CT scan shows a progressive size reduction of primary tumor localized in the left superior lobe (B, C) in comparison with baseline (A). For clinical case 2, the CT scan (E) shows dimensional increase of primary tumor localized in the right superior lobe in comparison with baseline (D). This increase could be explained as a pseudo-progression because of the reduction of the same lesion in the subsequent CT scan (F). For clinical case 3, the CT scan (H, I) shows a size reduction of primary tumor localized in the left superior lobe in comparison with baseline (G); in H, the signs of a partial cavitation (arrow) for necrosis can also be observed. (J) The graph shows the changes in the sum of the diameters of target lesions at T0, T1 and T2. The classification of response according to the RECIST criteria is associated with each time point. mm, millimeters; PD, progressive disease; SD, stable disease; PR, partial response.
fimmu-12-672219-g001.jpg
PMC8191501_03_fimmu-12-672219-g001.jpg
f1
At the subsequent evaluation two months later (T2), the CT scan still showed stable disease according with RECIST criteria ( Figures 1G-I ,  J ).
PMC8191501_03
Clinical imaging. For clinical case 1, the CT scan shows a progressive size reduction of primary tumor localized in the left superior lobe (B, C) in comparison with baseline (A). For clinical case 2, the CT scan (E) shows dimensional increase of primary tumor localized in the right superior lobe in comparison with baseline (D). This increase could be explained as a pseudo-progression because of the reduction of the same lesion in the subsequent CT scan (F). For clinical case 3, the CT scan (H, I) shows a size reduction of primary tumor localized in the left superior lobe in comparison with baseline (G); in H, the signs of a partial cavitation (arrow) for necrosis can also be observed. (J) The graph shows the changes in the sum of the diameters of target lesions at T0, T1 and T2. The classification of response according to the RECIST criteria is associated with each time point. mm, millimeters; PD, progressive disease; SD, stable disease; PR, partial response.
fimmu-12-672219-g001.jpg
PMC8191501_03_fimmu-12-672219-g001.jpg
f1
At the subsequent evaluation two months later (T2), the CT scan still showed stable disease according with RECIST criteria ( Figures 1G-I ,  J ).